RB Update Due Soon, page-54

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 54 Last

Share
Profile

Follow
rustys33

1,879 Posts.

536

21/12/20

13:04

Post #: 49727494
Share

Originally posted by Elusive Lahood: ↑

My 2 cents...

If RB had walked away, ResApp would have been required to announce this to the market this morning (in accordance with their continuous disclosure obligations).

Outcome:
Given that there has not been an announcement to this effect, the arrangement with RB must still be on foot (i.e. neither part has decided to terminate the agreement at this stage).

So why no announcement today?
The original ASX announcement regarding the RB MOU didn't necessarily contemplate an announcement being made at the conclusion of the 6 month period. Instead, the relevance of the 6 month period, is that each party has now acquired the right to terminate the MOU agreement given that a JDA has not been signed within that period... "ResApp and RB have agreed to exclusively work together to build and test a prototype app for consumers to self-assess, or assess with the assistance of a pharmacist, their respiratory symptoms. This exclusivity may be terminated by either party if a joint development agreement is not signed within six months."
https://www.resapphealth.com.au/wp-content/uploads/2020/06/2075460.pdf

My hypothesis:
ResApp management didn't feel the need today to announce that negotiations with RB to finalise a JDA remain ongoing...
Why? An announcement to this effect might have actually raised more questions than answers, as they probably wouldn't have been able to put any timelines on the finalisation of the JDA, or provide any further context regarding the status of the current negotiations. As we know, at RB's request, Tony has been very tight lipped about the work ResApp has been doing with RB to date...

As such, while i was expecting an update today, I'm not totally surprised not to see anything. In summary, the apparent positive of the silence, is that the RB partnership still appears to be a live one...

Expand

Makes perfect sense. However, the same could be applied to Sanofi. Maybe if that had been handled better there would not be as much angst.

RAP Price at posting: 7.7¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Week 42 Wrap: HotCopper's top picks; new ASX 200 record; world yawns at war

TLG

Talga Group wins key permit for flagship graphite mine in Sweden

IRX

InhaleRX snags $38.5M in funding from VC biotech funder Clendon

SWP

Swoop lobs $18M offer at microcap telecom Vonex – in which it holds 19.9%

MTH

Mithril's drilling in Mexico picks up silver at 997g/t, gold at 28g/t

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

M4M

Macro, Norden set up transport solutions initiative for West Pilbara

NVU

Nanoveu surges 10% after benchmark testing for new AI chip begins

What's causing the cost-of-living crisis, and how to navigate it

SNX

Sierra Nevada raises $2M for silver exploration at Blackhawk